Dysregulated activity or expression of eIF3 or its subunits is associated with a wide array of human diseases, including a host of cancers, neurodegenerative diseases, and viral infections, but how these outcomes are tied to disruption of eIF3 remains poorly understood. Here, EIF3A is linked to cancer.